In a corner of telehealth that is often criticized as a “grinder,” Mochi Health is betting that the real difference is the opposite: keeping patients and provider trust for a long time.
The knock on direct-to-consumer telehealth is that it optimizes transactions. The patient arrives, the questionnaire is processed, the prescription is sent, and the relationship ends successfully, until the next refill or the next situation sends them back down the funnel.
The model works well for simple needs but is not appropriate for the chronic, complex conditions that account for most of the health care costs and complications.
Mochi Health, founded by Myra Ahmad in 2022, builds on the opposite premise: that continuity, not exit, is what patients really need and what a telehealth company should be designed to deliver.
Mochi’s goal is to keep the patient with the same provider for all needs and in the long run, Ahmad argues that means better care and a more secure business.
The continuation of the problem is intended to solve
Ahmad traces the company to a structural failure he saw in research: patients losing care in the gaps between professionals.
“Our health care system is designed for billing codes rather than clinical outcomes,” she told Women of Wearables in April 2026.
“Patients bounce from specialist to specialist, but no one seems to ‘own’ their care.” If doctors are paid based on what they bill, rather than whether patients progress or stay in treatment, there is nothing in the system that rewards keeping the patient connected to a single, accountable relationship.
The single-use prescription model, however convenient it may be, also presents that gap online. It can prescribe medicine, but it cannot easily detect when treatment is failing, adjust the plan as the patient’s condition changes, or direct care across several conditions that often go together.
Continuity is Mochi’s proposed solution. Constant static relationships between prescriptions instead of individual resets.
What does the resume look like on the platform
In fact, Mochi frameworks take care of a selected provider and an ongoing support team rather than a single visit.
Patients choose their provider and, according to the company’s site, get unlimited access to a physician and care team, nutrition coaching with a registered dietitian, in-app messaging, and 24/7 support throughout their journey.
The company looks at care as it goes beyond the initial prescription, and its member testimonials echo a similar theme, including one patient who said they chose Mochi because they “wanted real support, not just a prescription.”
That continuity is designed to accommodate circumstances and time. Ahmad said patients can stay with a trusted provider across 15 treatment areas and more than 120 conditions, and that the increase in weight loss was driven by patients asking their Mochi providers to handle more of their care.
The environment he describes is the “primary care home,” a single trusting relationship where the patient can control the full range of their life rather than being reassembled in all disconnected ways.
Round-the-clock access to providers, nutritionists, and nutritionists is designed to make that relationship ongoing rather than episodic.
Why is it so important for women
Ahmad points out that continuity is not an aspiration but a practical necessity. “For women who are managing their obesity, as well as other health issues such as PCOS, perimenopause, or fertility issues, continued care is important,” she said.
A patient-centered model with a single provider who understands the whole picture is, in his practice, what good care for these patients should always look like.
Mochi’s testimony echoes this point, including a member who said the forum was the first place her PCOS and GLP-1 journey “was finally taken seriously.”
Business logic
A company built on one-time prescriptions must continue to find patients, an expensive press in a segment where marketing costs are high.
A company built on existing relationships can grow by deepening them, adding treatment areas as patients request them rather than acquiring new clients individually.
Mochi’s expansion from slimming to skin, reproductive health, menopause, and longevity follows that logic: each new area is a reason for an existing patient to stay rather than chasing a new patient. Retention, in this model, is the clinical goal and engine of growth.
Warnings
Continuity is easier to promise than to keep. Mochi’s claims warrant general scrutiny. Keeping patients engaged long-term is difficult for any provider.
The expansion in many cases also raises the bar: a platform that promises continuity in all 120-plus cases faces the challenge of maintaining quality and real communication in all of them, rather than simply offering more payment routes.
There is a real danger that “continuation” becomes a layer of marketing on top of what still works, a chain of commandments.
The best read is that Mochi identified a real weakness in transactional telehealth and built his model to address it.
In a field that is often accused of selling documents, Mochi is betting that what should be sold is the relationship that has passed.
